Effect of CD40 ligand on the course of murine histoplasmosis

Medical Mycology

Volumn 40, Issue 5, 2002, Pages 501-505

  Wheat, L J ^a,b,c   Durkin, M ^a,c   Schnizlein Bick, C ^a   Bassey, E ^a,c   Kohler, S ^b,c   Connolly, P ^a,c   Goldberg, J ^a,c   Garringer, T ^a,c   Brizendine, E ^a   Thomas, E K ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Histoplasmosis Reference Laboratory   (United States)

^d AMGEN INC   (United States)

Author keywords

Latency; Paracoccidioides brasiliensis tissue morphology

Indexed keywords

AMPHOTERICIN B; CD4 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG POTENTIATION; FUNGAL STRAIN; FUNGUS ISOLATION; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; LOW DRUG DOSE; LUNG; MONITORING; MOUSE; NONHUMAN; SPLEEN; T LYMPHOCYTE; TREATMENT FAILURE; YEAST;

ANIMALS; ANTIGENS, CD4; CD40 LIGAND; HISTOPLASMOSIS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LUNG; MICE;

AJELLOMYCES; AJELLOMYCES CAPSULATUS; ANIMALIA; FUNGI; MURINAE; PARACOCCIDIOIDES BRASILIENSIS;

EID: 0036809866     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.40.5.501.505     Document Type: Article

References (16)

1. Deepe GS, Jr., Bullock WE. Histoplasmosis: A granulomatous inflammatory response. In: Gallin JI, Goldstein IM, et al., eds. Inflammation: Basic Principals and Clinical Correlates. New York: Raven, 1988: 733-749.
2. Wu-Hsieh BA, Lee GS, Franco M, et al. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 60: 4230-4238.
3. Banchereau J. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 123: 881-922.
4. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80-82.
5. Grewal IS, Flavell RA. CD40 ligand at the center of the universe? Immunol Res 1997; 16: 59-70.
6. Notarangelo LD, Duse M, Ugario AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 1992; 3: 101-121.
7. Kamanaka M, Yu P, Yasui T, et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996; 4: 275-281.
8. Campbell KA, Ovendale PJ, Kennedy MK, et al. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996; 4: 283-289.
9. Zhou P, Seder RA. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum. J Exp Med 1998; 187: 1315-1324.
10. Jennings SR, Bonneau RH, Smith PM, et al. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8 positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell Immunol 1991; 133: 234-252.
11. Worsham PL, Goldman WE. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol 1988; 26: 137-143.
12. Connolly P, Wheat J, Schnizlein-Bick C, et al. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice. Antimicrob Agents Chemother 1999; 43: 322-328.
13. Durkin MM, Connolly PA, Wheat LJ. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol 1997; 35: 2252-2255
14. Dupuis M, McDonald DM. Perspective: Dendritic-cell regulation of lung immunity. Am J Respir Cell Mol Biol 1997; 17: 284-286.
15. Masten BJ, Yate AM, Koga P, et al. Characterization of accessory molecules in murine lung dendritic cell function: Roles for CD80, CD86, CD54, and CD40L. Am Respir Cell Mol Biol 1997; 16: 335-342.
16. Chougnet C, Thomas E, Landay A, et al. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients. Eur J Immunol 1998; 28: 646-656.